Lorenzo Simonelli - 23 Jul 2025 Form 4 Insider Report for Baker Hughes Co (BKR)

Signature
/s/ Fernando Contreras, Attorney-in-fact
Issuer symbol
BKR
Transactions as of
23 Jul 2025
Transactions value $
-$15,273,201
Form type
4
Filing time
25 Jul 2025, 16:14:37 UTC
Previous filing
12 Mar 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Simonelli Lorenzo Chairman, President and CEO, Director 575 NORTH DAIRY ASHFORD ROAD, SUITE 100, HOUSTON /s/ Fernando Contreras, Attorney-in-fact 25 Jul 2025 0001709160

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BKR Class A Common Stock Options Exercise $8.12M +353K +42% $22.98 1.19M 23 Jul 2025 Direct F1
transaction BKR Class A Common Stock Sale -$23.4M -527K -44.1% $44.42 668K 23 Jul 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BKR Stock Option (Right to Buy) Options Exercise $0 -353K -100% $0.00 0 23 Jul 2025 Class A Common Stock 353K $22.98 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2025.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.00 to $44.88, inclusive. Details on the number of shares sold at each separate price will be provided to the Issuer, any shareholder of the Issuer, or staff of the Securities and Exchange Commission upon request.
F3 The stock option was granted on January 23, 2019 and vested in three equal annual installments beginning one year from the date of grant.